Back to Search Start Over

Advanced glycation endproducts and dicarbonyls in end-stage renal disease: associations with uraemia and courses following renal replacement therapy

Authors :
Jeroen P. Kooman
Remy J.H. Martens
Constantijn J.A.M. Konings
Tom Cornelis
Adelheid Gauly
Bernard Canaud
Maarten H. L. Christiaans
Frank Stifft
Natascha J. H. Broers
Frank M. van der Sande
Casper G. Schalkwijk
Marc M. H. Hermans
Jean L.J.M. Scheijen
RS: Carim - V02 Hypertension and target organ damage
Interne Geneeskunde
RS: NUTRIM - R3 - Respiratory & Age-related Health
MUMC+: MA Nefrologie (9)
MUMC+: MA Alg Onderzoek Interne Geneeskunde (9)
RS: Carim - V01 Vascular complications of diabetes and metabolic syndrome
Source :
Clinical Kidney Journal, 13(5), 855-866. Oxford University Press, Clinical Kidney Journal
Publication Year :
2020

Abstract

Background End-stage renal disease (ESRD) is strongly associated with cardiovascular disease (CVD) risk. Advanced glycation endproducts (AGEs) and dicarbonyls, major precursors of AGEs, may contribute to the pathophysiology of CVD in ESRD. However, detailed data on the courses of AGEs and dicarbonyls during the transition of ESRD patients to renal replacement therapy are lacking. Methods We quantified an extensive panel of free and protein-bound serum AGEs [N∈-(carboxymethyl)lysine (CML), N∈-(carboxyethyl)lysine (CEL), Nδ-(5-hydro-5-methyl-4-imidazolon-2-yl)ornithine (MG-H1)], serum dicarbonyls [glyoxal (GO), methylglyoxal (MGO), 3-deoxyglucosone (3-DG)] and tissue AGE accumulation [estimated by skin autofluorescence (SAF)] in a combined cross-sectional and longitudinal observational study of patients with ESRD transitioning to dialysis or kidney transplantation (KTx), prevalent dialysis patients and healthy controls. Cross-sectional comparisons were performed with linear regression analyses, and courses following renal replacement therapy were analysed with linear mixed models. Results Free and protein-bound AGEs, dicarbonyls and SAF were higher in chronic kidney disease (CKD) Stage 5 non-dialysis (CKD 5-ND; n = 52) and CKD Stage 5 dialysis (CKD 5-D; n = 35) than in controls (n = 42). In addition, free AGEs, protein-bound CML, GO and SAF were even higher in CKD 5-D than in CKD5-ND. Similarly, following dialysis initiation (n = 43) free and protein-bound AGEs, and GO increased, whereas SAF remained similar. In contrast, following KTx (n = 21), free and protein-bound AGEs and dicarbonyls, but not SAF, markedly declined. Conclusions AGEs and dicarbonyls accumulate in uraemia, which is even exaggerated by dialysis initiation. In contrast, KTx markedly reduces AGEs and dicarbonyls. Given their associations with CVD risk in high-risk populations, lowering AGE and dicarbonyl levels may be valuable.

Details

Language :
English
ISSN :
20488505
Database :
OpenAIRE
Journal :
Clinical Kidney Journal, 13(5), 855-866. Oxford University Press, Clinical Kidney Journal
Accession number :
edsair.doi.dedup.....9d023c9d14634b439cc37191cfbce2bd